S&P 500
(1.26%) 5 127.79 points
Dow Jones
(1.18%) 38 676 points
Nasdaq
(1.99%) 16 156 points
Oil
(-1.22%) $77.99
Gas
(5.65%) $2.15
Gold
(0.02%) $2 310.10
Silver
(-0.16%) $26.79
Platinum
(0.38%) $966.30
USD/EUR
(-0.36%) $0.929
USD/NOK
(-1.07%) $10.87
USD/GBP
(-0.11%) $0.797
USD/RUB
(0.36%) $91.45

Обновления в реальном времени для Smith & Nephew SNATS Inc. [SNN]

Биржа: NYSE Сектор: Healthcare Промышленность: Medical - Devices
Последнее обновление3 май 2024 @ 23:00

1.39% $ 24.78

Live Chart Being Loaded With Signals

Commentary (3 май 2024 @ 23:00):
Profile picture for Smith & Nephew SNATS Inc.

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures...

Stats
Объем за сегодня 1.06M
Средний объем 959 743
Рыночная капитализация 10.80B
EPS $0 ( 2024-02-27 )
Дата следующего отчета о доходах ( $0 ) 2024-08-01
Last Dividend $0.288 ( 2023-10-05 )
Next Dividend $0 ( N/A )
P/E 41.30
ATR14 $0.0100 (0.04%)

Объем Корреляция

Длинно: -0.17 (neutral)
Кратко: 0.78 (moderate)
Signal:(56.487) Neutral

Smith & Nephew SNATS Inc. Корреляция

10 Самые положительные корреляции
10 Самые отрицательные корреляции

Вы знали?

Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).

Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.

Smith & Nephew SNATS Inc. Корреляция - Валюта/Сырье

The country flag 0.46
( neutral )
The country flag 0.84
( strong )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag -0.51
( weak negative )
The country flag 0.59
( weak )

Smith & Nephew SNATS Inc. Финансовые показатели

Annual 2023
Выручка: $5.55B
Валовая прибыль: $3.70B (66.70 %)
EPS: $0.600
FY 2023
Выручка: $5.55B
Валовая прибыль: $3.70B (66.70 %)
EPS: $0.600
FY 2022
Выручка: $5.22B
Валовая прибыль: $3.70B (70.85 %)
EPS: $0.510
FY 2021
Выручка: $5.21B
Валовая прибыль: $3.67B (70.40 %)
EPS: $1.196

Financial Reports:

No articles found.

Smith & Nephew SNATS Inc. Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0.288
(N/A)
$0
(N/A)
$0.462
(N/A)
$0
(N/A)
$0
(N/A)
$0.288
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Smith & Nephew SNATS Inc. Dividend Information - Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.49 - Stable (10.24%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.139 2000-05-04
Last Dividend $0.288 2023-10-05
Next Dividend $0 N/A
Payout Date 2023-11-01
Next Payout Date N/A
# dividends 48 --
Total Paid Out $10.43 --
Avg. Dividend % Per Year 1.50% --
Score 4.34 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 4.49
Div. Directional Score 7.54 --
Next Divdend (Est)
(2024-09-30)
$0.288 Estimate 7.53 %
Dividend Stability
0.30 Poor
Dividend Score
4.34
Pay Frequency
Semi-Annually
Yearly Payout
Year Amount Yield
2000 $0.194 2.88%
2001 $0.146 1.58%
2002 $0.154 1.28%
2003 $0.169 1.36%
2004 $0.184 1.10%
2005 $0.194 0.96%
2006 $0.204 1.08%
2007 $0.223 1.07%
2008 $0.247 1.07%
2009 $0.271 2.08%
2010 $0.299 1.45%
2011 $0.328 1.56%
2012 $0.414 2.12%
2013 $0.532 2.39%
2014 $0.560 1.98%
2015 $0.608 1.69%
2016 $0.626 1.80%
2017 $0.616 2.05%
2018 $0.734 2.10%
2019 $0.728 2.00%
2020 $0.750 1.55%
2021 $0.750 1.75%
2022 $0.750 2.14%
2023 $0.750 2.75%
2024 $0 0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NYSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
LOMA Dividend Knight 2023-06-30 Quarterly 2 5.23% 8.53
PVL Dividend King 2023-11-15 Monthly 14 9.37% 8.50
KIO Dividend Royal 2023-12-14 Monthly 12 7.05% 8.50
NCV Dividend Royal 2024-02-09 Monthly 22 7.68% 8.50
SCM Dividend King 2023-12-15 Monthly 13 7.08% 8.50
MTR Dividend Diamond 2023-10-30 Monthly 39 10.10% 8.50
SBR Dividend Royal 2023-11-14 Monthly 38 7.74% 8.50
PDI Dividend Royal 2023-11-10 Monthly 13 7.86% 8.50
SJT Dividend Royal 2023-11-29 Monthly 39 12.52% 8.50
GOF Dividend Royal 2023-11-14 Monthly 18 8.03% 8.50

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.04751.5009.0510.00[0 - 0.5]
returnOnAssetsTTM0.02631.2009.1210.00[0 - 0.3]
returnOnEquityTTM0.05021.500-0.553-0.830[0.1 - 1]
payoutRatioTTM1.247-1.00010.00-10.00[0 - 1]
currentRatioTTM1.7750.8006.134.90[1 - 3]
quickRatioTTM0.6790.800-0.709-0.567[0.8 - 2.5]
cashRatioTTM0.1331.500-0.372-0.558[0.2 - 2]
debtRatioTTM0.294-1.5005.09-7.64[0 - 0.6]
interestCoverageTTM5.491.0009.089.08[3 - 30]
operatingCashFlowPerShareTTM1.3842.009.5410.00[0 - 30]
freeCashFlowPerShareTTM0.4122.009.7910.00[0 - 20]
debtEquityRatioTTM0.564-1.5007.75-10.00[0 - 2.5]
grossProfitMarginTTM0.6881.0001.8621.862[0.2 - 0.8]
operatingProfitMarginTTM0.1371.0009.259.25[0.1 - 0.6]
cashFlowToDebtRatioTTM0.2051.0009.979.97[0.2 - 2]
assetTurnoverTTM0.5530.8009.647.72[0.5 - 2]
Total Score10.60

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM40.621.0006.000[1 - 100]
returnOnEquityTTM0.05022.50-0.356-0.830[0.1 - 1.5]
freeCashFlowPerShareTTM0.4122.009.8610.00[0 - 30]
dividendYielPercentageTTM3.071.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM1.3842.009.5410.00[0 - 30]
payoutRatioTTM1.2471.50010.00-10.00[0 - 1]
pegRatioTTM-1.5901.500-10.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1091.0009.770[0.1 - 0.5]
Total Score4.49

Smith & Nephew SNATS Inc.

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

О Торговые сигналы

Данные торговые сигналы, представленные на этой странице, помогают определить, когда следует ПОКУПАТЬ или ПРОДАВАТЬ NA. Сигналы имеют задержку более 1 минуты. Пожалуйста, примите во внимание, что существует вероятность ошибки или неточностей в силу различных микро и макро факторов влияющих на фондовые рынки.

Данные тор“о”ые сигна“ы не являются определен“ыми, и getagraph.com не несет ответственности за какие-либо действия, предпринятые в от“ошении этих сигналов, как описано в Terms of Use. Сигналы основаны на широком спектре индикаторов технического анализа